World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
53312
World Ranking
9480
National Ranking
372

Overview

Jan Delabie is affiliated with the University Health Network in Canada and has contributed extensively to research in the medical field, focusing strongly on lymphoma and hematological malignancies. Their body of work is published primarily in journals concerned with oncology, pathology, and hematology.

Delabie's research spans multiple subfields of medicine, including:

  • Pathology and Forensic Medicine
  • Genetics
  • Oncology
  • Molecular Biology
  • Immunology

The main themes reflected in their research output cover areas such as:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Blood groups and transfusion
  • Viral-associated cancers and disorders
  • Cutaneous lymphoproliferative disorders research
  • CAR-T cell therapy research
  • Cancer-related gene regulation

Jan Delabie has published prominently in the following venues:

  • Blood (16 publications)
  • Hematological Oncology (4 publications)
  • Blood Advances (3 publications)
  • American Journal of Hematology (2 publications)
  • ECS Meeting Abstracts (2 publications)

Their most cited recent papers include:

  • Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18, published in 2020 in Blood Advances
  • Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study), published in 2024 in Blood
  • Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature review, published in 2021 in Pathology - Research and Practice
  • CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH-GRADE B-CELL LYMPHOMA, NOS - AN LLMPP PROJECT, published in 2021 in Hematological Oncology
  • The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels, published in 2021 in American Journal of Hematology

Delabie has collaborated frequently with several co-authors, including:

  • Kerry J. Savage
  • Timothy C. Greiner
  • Andrew L. Feldman
  • Graham W. Slack
  • Pedro Farinha

Best Publications

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Nathalie A. Johnson;Graham W. Slack;Kerry J. Savage;Joseph M. Connors

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

    Georg Lenz;R. Eric Davis;Vu N. Ngo;Lloyd Lam

  • Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

    Christian H. Geisler;Arne Kolstad;Anna Laurell;Niels S. Andersen

  • A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

    William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris

  • Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

    Francesco D'Amore;Thomas Relander;Grete F. Lauritzsen;Esa Jantunen

  • Cyclin D1-negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling

    Kai Fu;Dennis D. Weisenburger;Timothy Charles Greiner;Sandeep Dave

  • Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin embedded tissue

    David W. Scott;George W. Wright;P. Mickey Williams;Chih Jian Lih

Frequent Co-Authors

Elias Campo
Elias Campo University of Barcelona
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Wing C. Chan
Wing C. Chan City of Hope
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
German Ott
German Ott Robert Bosch (Germany)
Dennis D. Weisenburger
Dennis D. Weisenburger University of Nebraska Medical Center
Erlend B. Smeland
Erlend B. Smeland Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field offers a wide range of rewarding online degree and certification options for those seeking alternative medical career paths. Many students look to flexible online programs to fit their studies around busy schedules, while saving on costs associated with traditional education.

Health information technology programs online provide foundational knowledge for careers in managing patient data and healthcare records—a rapidly growing sector as digital health systems expand. For those interested in the administrative side of healthcare, billing and coding classes online make it possible to launch a career in medical coding and insurance claims, all from home at your own pace.

If clinical practice is your goal, pursuing a nursing pathway is popular. Aspiring advanced practice nurses often seek the cheapest fnp programs online to become family nurse practitioners, while registered nurses should consider researching how much does online nursing school cost before enrolling in a program.

Each of these online options opens doors to in-demand, vital roles in the US healthcare landscape—often at a lower cost and with more scheduling flexibility than on-campus programs.

Best Scientists Citing Jan Delabie

Trending Scientists

Recently Published Articles